Ignite Creation Date:
2025-12-24 @ 9:11 PM
Ignite Modification Date:
2025-12-31 @ 12:32 PM
Study NCT ID:
NCT05470504
Status:
RECRUITING
Last Update Posted:
2025-12-01
First Post:
2022-07-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Growth Hormone Inhibition Using Pegvisomant in Severe Insulin Resistance
Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-01-23
Start Date Type:
ACTUAL
Primary Completion Date:
2028-01-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-01-31
Completion Date Type:
ESTIMATED
First Submit Date:
2022-07-16
First Submit QC Date:
None
Study First Post Date:
2022-07-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-27
Last Update Post Date:
2025-12-01
Last Update Post Date Type:
ESTIMATED